Cargando…

Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation

BACKGROUND: Long-term outcomes of lung transplantation are severely affected by comorbidities and development of chronic rejection. Among the comorbidities, kidney insufficiency is one of the most frequent and it is mainly caused by the cumulative effect of calcineurin inhibitors (CNIs). Currently,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benazzo, Alberto, Cho, Ara, Nechay, Anna, Schwarz, Stefan, Frommlet, Florian, Wekerle, Thomas, Hoetzenecker, Konrad, Jaksch, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783986/ https://www.ncbi.nlm.nih.gov/pubmed/33397442 http://dx.doi.org/10.1186/s13063-020-04843-9

Ejemplares similares

Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation
por: Benazzo, A., et al.
Publicado: (2022)

Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience
por: Benazzo, Alberto, et al.
Publicado: (2019)

Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus
por: Shihab, F., et al.
Publicado: (2017)

Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
por: Guthoff, Martina, et al.
Publicado: (2020)

Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil
por: Traitanon, Opas, et al.
Publicado: (2019)

Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia
por: Spyridonidis, A, et al.
Publicado: (2011)

The Effect of Prone Positioning After Lung Transplantation
por: Frick, Anna Elisabeth, et al.
Publicado: (2023)

Efficacy and Safety of Low-Dose Everolimus as Maintenance Immunosuppression in Cardiac Transplant Recipients
por: Fuchs, Uwe, et al.
Publicado: (2012)

Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial
por: Kim, Hyung Duk, et al.
Publicado: (2021)

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer
por: Huijts, Charlotte M, et al.
Publicado: (2011)

Alemtuzumab induction in pediatric kidney transplantation
por: Kaabak, Michael M, et al.
Publicado: (2013)

Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients
por: de Boer, S. E., et al.
Publicado: (2021)

Gamma-Glutamyltransferase at the Time of Listing May Predict Irreversible Severe Cholangiopathy After Lung Transplantation for COVID19-ARDS
por: Schwarz, S., et al.
Publicado: (2022)

Simultaneous pectus excavatum correction and lung transplantation–A case series
por: Rahimi, Nina, et al.
Publicado: (2020)

Multiple intracardiac benign tumors treated with low-dose everolimus
por: Beyazal, Meryem, et al.
Publicado: (2022)

Alemtuzumab induction therapy in solid organ transplantation
por: Friend, Peter J
Publicado: (2013)

Comparison of donor scores in bilateral lung transplantation—A large single‐center analysis
por: Schwarz, Stefan, et al.
Publicado: (2020)

Impact of Prone Positioning after Lung Transplantation - A Single Center Experience
por: Frick, A.E., et al.
Publicado: (2021)

A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients
por: Tang, Jiang-Tao, et al.
Publicado: (2018)

Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis
por: Shoughy, Samir S, et al.
Publicado: (2016)

Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
por: Lee, John R., et al.
Publicado: (2015)

An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation
por: Ekberg, Jana, et al.
Publicado: (2014)

Tacrolimus-induced gingival hyperplasia and recovery from tacrolimus to everolimus switching
por: Oral, Alihan, et al.
Publicado: (2019)

Prioritizing direct heart procurement in organ donors after circulatory death does not jeopardize lung transplant outcomes
por: Schwarz, Stefan, et al.
Publicado: (2022)

A four-drug combination therapy consisting of low-dose tacrolimus, low-dose mycophenolate mofetil, corticosteroids, and mizoribine in living donor renal transplantation: A randomized study
por: Yan, Tian-zhong, et al.
Publicado: (2016)

Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
por: Luo, Cong, et al.
Publicado: (2021)

Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus
por: Hurtado-Sierra, Daniel, et al.
Publicado: (2023)

MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction
por: Miyahara, Naofumi, et al.
Publicado: (2022)

Pharmacogenetics Based Dose Prediction Model for Initial Tacrolimus Dosing in Renal Transplant Recipients
por: Srinivas, Lekshmy, et al.
Publicado: (2021)

Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients
por: Bremer, Sebastian C. B., et al.
Publicado: (2018)

Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years
por: Saliba, Faouzi, et al.
Publicado: (2019)

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
por: Thölking, Gerold, et al.
Publicado: (2020)

Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial
por: Zuckermann, Andreas, et al.
Publicado: (2011)

A retrospective analysis of the safety and efficacy of low dose tacrolimus (FK506) for living donor liver transplant recipients
por: Wu, Zhengshan, et al.
Publicado: (2013)

The therapeutic effect of switching from tacrolimus to low-dose cyclosporine A in renal transplant recipients with BK virus nephropathy
por: Chen, Xu-Tao, et al.
Publicado: (2019)

Low molecular weight heparin versus unfractioned heparin for anticoagulation during perioperative extracorporeal membrane oxygenation: A single center experience in 102 lung transplant patients
por: Gratz, Johannes, et al.
Publicado: (2020)

Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate
por: Lee, Won-Seok, et al.
Publicado: (2016)

Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome
por: Albaghdadi, Ahmad J. H., et al.
Publicado: (2021)

Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial
por: Nashan, Bjorn, et al.
Publicado: (2015)

Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome
por: Admiraal, Rick, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ucimcg3sk2hkh0eeuqvnldg3fi